Clinical Trial Update: Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial [Phase 3]

View source ↗

Summary

Phase 3 CREATE trial evaluating carotid revascularization with ev3 arterial technology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease

Drugs mentioned

• ev3 Arterial Technology

Snippet

Sponsor: Medtronic Endovascular | Conditions: Carotid Artery Disease | Phase 3 | Status: COMPLETED